Nijhawan Pardeep bought EDSA
October 28, 2026 · Form 4 insider transaction
Nijhawan Pardeep bought 27,602 shares of Edesa Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These restricted stock awards ("RSUs") represent awards received in lieu of 90% of Reporting Person's monthly base salary otherwise payable in cash, reflecting the increase in Reporting Person's annual base salary from $357,696 to $657,423, retroactive for the period from July 1, 2026 through October 10, 2026. The number of RSUs was determined by dividing such portion of the base salary by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through October 27, 2026.